Skoda Auto Volkswagen India announced wednesday that it had exported more than 25,000 cars in the current year so far and surpassed the milestone of shipping the 5,000th car produced in the country, despite the complicated global call.
Car number 500,000 is a left-hand drive Vento sedán, which is from a batch of 982 cars shipped to Mexico from the port of Mumbai, Skoda Auto Volkswagen India Private Ltd (SAVWIPL) said in a statement.
Europe’s leading automaker began exporting its cars from India in 2010 with 65 Sets of Volkswagen Vento manufactured in India for the South African market.
Since then, the company has continued to grow gradually to achieve the “Made in India” presence in 61 countries in South America, Central America, Africa, the Indian subcontinent, Southeast Asia, GCC countries and the Caribbean region, The Version said.
Skoda Auto Volkswagen India exported more than 25,000 cars in the current year, marking consistent export functionality despite the plight around the world, the company said.
“Exports are an integral component of our strategy and the structure of five sets of lakh is a step for the company. Cars produced at ‘KODA AUTO Volkswagen’ production sites illustrate the high-quality criteria we apply worldwide and in India,” said Skoda Auto Volkswagen India. Director General Gurpratap Boparai.
He added that achievement is gaining importance “as we continue to export cars despite the demanding situations in the industry due to COVID-19 disruptions. “
Over the next few years, the company will produce cars on the new MBQ A0 IN platform with a high degree of location and will continue to explore export markets for India 2. 0 products, he said.
The India 2. 0 project, which has an investment of Rs 8,000 crore, points to the presence in the domestic market with Car Models express to India through a compromised platform.
The 4 new products developed for the Indian market for Skoda Auto and Volkswagen, consisting of SUVs and Notchbacks, will be evaluated for export to markets that require physically powerful and effective cars, he said.
Essential Coronavirus The center may withdraw plasma treatment from COVID-19 treatment; reinfection will most likely occur if antibodies are minimized within five months of recovery, according to ICMR